SAB Biotherapeutics Inc（SABS）價格預測SABSSAB Biotherapeutics Inc

Alphio's SABS stock price prediction model matches the current SAB Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.17 (-0.24%). The 1-week path is $3.21 (+0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

SAB Biotherapeutics Inc is a good buy right now due to its current price of $3.30, which is significantly below the analyst price targets of $11 and $13. The stock has shown a strong recent performance with a 5-day change of +18.28%, indicating positive momentum. However, the primary risk is the company's ongoing net losses, with a reported net loss of $18.9 million for Q1 2026, which raises concerns about its financial health.

SAB Biotherapeutics Inc (SABS) last closed at $3.1800001, gaining +1.92%. These facts feed the 1-day and 1-week SABS price prediction above.